Caption Management »

Aclaris Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $420 400 1.05
2023-09-30 $5.6M 822k 6.85
2023-06-30 $461k 45k 10.37
2023-03-31 $7.1M 879k 8.09
2021-06-30 $585k 33k 17.57

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Citadel Advisors
Vanguard Group
Millennium Management
D. E. Shaw & Co
Tang Capital Management
GSA Capital Partners
Two Sigma Investments
Two Sigma Advisers
Monaco Asset Management SAM
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Samsara BioCapital
Goldman Sachs Group
Citigroup

View all funds holding Aclaris Therapeutics